Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
44,950
Period ended Jun 30, 2026
Change on a year earlier
+0.7%
44,644 in Q2 2025
History
68 quarters
Since Q4 2008
Sources
67
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Paid-In Capital ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 44,950 | +0.7% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 45,176 | +0.8% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 45,029 | +0.7% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 44,832 | +0.7% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 44,644 | +0.6% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 44,816 | +0.5% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 44,704 | +0.4% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 44,530 | +0.4% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 44,362 | +0.3% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 44,598 | +0.3% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 44,509 | +0.3% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 44,358 | +0.3% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 44,219 | +0.2% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 44,467 | +0.4% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 44,379 | +0.3% | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 44,243 | +0.2% | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 44,115 | +0.2% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 44,275 | +11.8% | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 44,238 | +11.7% | Form 10-K (filed 2022-02-25) ↗ |
| Q3 2021 | Sep 30, 2021 | 44,149 | +11.8% | Form 10-Q (filed 2021-11-05) ↗ |
| Q2 2021 | Jun 30, 2021 | 44,039 | +11.9% | Form 10-Q (filed 2021-08-09) ↗ |
| Q1 2021 | Mar 31, 2021 | 39,613 | -0.2% | Form 10-Q (filed 2021-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 39,588 | -0.2% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 39,489 | -0.2% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 39,373 | -0.3% | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 39,697 | +2.4% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 39,660 | +2.2% | Form 10-K (filed 2020-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | 39,561 | -0.5% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 39,484 | -0.6% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 38,768 | -2.8% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 38,808 | -2.7% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 39,762 | -0.2% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 39,741 | -0.1% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 39,874 | -0.1% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 39,902 | -0.1% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 39,823 | -0.2% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | 39,776 | -0.3% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 39,899 | -0.6% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 39,939 | -0.7% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | 39,897 | -0.6% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 39,911 | -0.5% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 40,145 | -0.5% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 40,222 | -0.5% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2015 | Sep 30, 2015 | 40,139 | -0.5% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 40,114 | -0.2% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | 40,355 | -0.2% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | 40,423 | -0.2% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | 40,340 | +1.1% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 40,199 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 40,450 | -0.7% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2013 | Dec 31, 2013 | 40,508 | -0.3% | Form 10-K (filed 2014-02-27) ↗ |
| Q2 2013 | Sep 30, 2013 | 39,909 | -1.4% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 40,727 | +0.2% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | 40,646 | 0.0% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 40,471 | -0.6% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 40,550 | -0.3% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 40,652 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 40,663 | -0.1% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 40,717 | +0.4% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2011 | Jun 30, 2011 | 40,657 | +0.8% | Form 10-Q (filed 2011-08-08) ↗ |
| Q4 2010 | Dec 31, 2010 | 40,701 | +2.6% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 40,557 | +659.5% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 40,338 | +676.3% | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2010 | Mar 31, 2010 | 40,197 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 39,683 | +377.0% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | 5,340 | – | Form 10-Q (filed 2009-10-29) ↗ |
| Q2 2009 | Jun 30, 2009 | 5,196 | – | Form 10-Q (filed 2009-07-24) ↗ |
| Q4 2008 | Dec 31, 2008 | 8,319 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Merck Other Paid-In Capital ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_apic
See every metric in the Merck KPI table. Data updated Oct 26, 2026.